72.00
Finanzdaten der Mirum Pharmaceuticals Inc-Aktie (MIRM)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
14.52%
127.78
|
111.58 | 99.41 | 90.38 | 77.88 |
|
|
4.74%
132.77
|
126.77 | 123.64 | 103.06 | 102.11 |
| Benefits Costs and Expenses |
6.40%
133.24
|
125.23 | 123.78 | 104.27 | 101.88 |
| Costs And Expenses |
6.40%
133.24
|
125.23 | 123.78 | 104.27 | 101.88 |
| Operating Income/Loss |
67.14%
-4.989
|
-15.18 | -24.22 | -12.68 | -24.23 |
| Income/Loss From Continuing Operations Before Tax |
60.00%
-5.459
|
-13.65 | -24.37 | -13.89 | -24.00 |
| Income Tax Expense/Benefit |
60.93%
0.402
|
1.029 | -0.576 | 0.347 | 0.635 |
| Income/Loss From Continuing Operations After Tax |
60.07%
-5.861
|
-14.68 | -23.79 | -14.23 | -24.64 |
|
|
60.07%
-5.861
|
-14.68 | -23.79 | -14.23 | -24.64 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
1.71%
49.73
|
48.89 | 0.2058 | 47.78 | 47.24 |
| Diluted Average Shares |
1.71%
49.73
|
48.89 | 0.2058 | 47.78 | 47.24 |
| Basic Earnings Per Share |
60.00%
-0.12
|
-0.30 | -0.49 | -0.30 | -0.52 |
| Diluted Earnings Per Share |
60.00%
-0.12
|
-0.30 | -0.49 | -0.30 | -0.52 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):